Daniel Howard

Gold Strike Resources' transformational acquisition and $15M financing create a new powerhouse in Yukon's prolific Tombstone Gold Belt. A new gold rush?

A secretive contract for advanced environmental sensors highlights a strategic shift in national security, leveraging miniaturized technology for defense.

A novel CRISPR-based therapy safely targets deadly E. coli in the gut, showing promise in the fight against antibiotic resistance and for protecting cancer patients.

Entrepreneur Daniel Gestetner discusses resilience, a $1B exit, and why true success isn't about winning at all costs in a revealing new podcast.

More women now manage household finances, but a new study reveals this empowerment comes with a heavy cost: heightened stress and declining financial confidence.

As Red Sea attacks disrupt global trade, companies are deploying autonomous systems to secure vital maritime corridors, heralding a new era of security.

The 135-year-old industry pioneer swept the 2026 TRSA awards, showcasing excellence in service, leadership, and sustainability across three continents.

With star-studded advisory board, a new biotech firm aims to turn routine dental visits into a frontline defense against oral cancer.

Central Pattana's massive expansion aims to transform Phuket into a year-round luxury hub. But can the island's infrastructure and environment keep pace?

TRG Latin America Acquisitions Corp. raises $200M in an IPO, targeting Argentina with the backing of emerging market veterans from The Rohatyn Group.

Celebrating its first anniversary, this derm-founded brand is swapping viral trends for sustainable growth, community building, and a new scholarship.

Treace Medical reports a Q4 revenue dip despite surgeon growth, revealing a strategic shift to lower-priced kits and a challenging 2026 outlook.

After a challenging year, InTest Corp. posts a strong Q4 rebound, driven by growth in non-semi markets. A robust backlog signals a promising 2026.

As revenues fall, Golden Entertainment reports a net loss for 2025 while its CEO prepares to take the company private in a complex, multi-billion dollar deal.

The Illinois-based bank crushed Q4 estimates with a 62.5% profit jump, outperforming sector trends through strong interest income and strategic growth.

As Acorn preps its Q4 results, we look at the microcap's macro impact on grid reliability, cell towers, and the burgeoning smart energy market.

SCOA Real Estate Partners announces two major industrial projects, signaling a strategic push into high-demand logistics hubs in Charlotte and Minneapolis.

Atlanta's Ameris Bank leaps to #15 on Forbes' Best Banks list, the largest by assets in the top tier. What's behind its impressive growth?

The biopharma company shatters records with 51% growth in its key drug, ASCENIV, and outlines a strategic overhaul aimed at long-term market dominance.

A new oral drug shows remarkable success in healing stubborn herpes lesions in people with HIV, offering a much-needed breakthrough for a vulnerable population.